Global Core Needle Biopsy Devices Market Insights, Size, and Forecast By Usage Type (Disposable, Reusable), By End User (Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers), By Application (Oncology, Cardiology, Musculoskeletal Disorders, Pulmonary Disorders), By Needle Type (Automated Needle, Manual Needle, Vacuum-Assisted Needle), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Key Companies, Competitive Analysis, Trends, and Projections for 2026-2035
Key Market Insights
Global Core Needle Biopsy Devices Market is projected to grow from USD 1.15 Billion in 2025 to USD 2.12 Billion by 2035, reflecting a compound annual growth rate of 6.7% from 2026 through 2035. This market encompasses a range of devices crucial for obtaining tissue samples for diagnostic purposes, particularly in cancer detection. The increasing global incidence of cancer, coupled with a growing emphasis on early and accurate diagnosis, serves as a primary driver for market expansion. Advancements in imaging technologies, such as MRI, CT, and ultrasound, are enhancing the precision and safety of core needle biopsies, further propelling their adoption. The market is also benefiting from a rising awareness regarding minimally invasive diagnostic procedures, which offer advantages like reduced patient discomfort, faster recovery times, and lower healthcare costs compared to traditional surgical biopsies. Furthermore, an aging global population, a demographic segment highly susceptible to various cancers, contributes significantly to the demand for effective biopsy solutions. Product innovation, particularly in needle design and automation, is a key trend, aiming to improve sample quality, reduce procedural time, and enhance user experience. The disposable segment holds a dominant share, indicating a strong preference for single-use products driven by infection control protocols and convenience.
Global Core Needle Biopsy Devices Market Value (USD Billion) Analysis, 2025-2035
2025 - 2035
www.makdatainsights.com
Despite robust growth, the market faces certain restraints. The high cost associated with advanced core needle biopsy devices and related procedures can be a barrier to adoption, particularly in developing economies with limited healthcare budgets. Moreover, the lack of skilled professionals trained in performing these complex procedures in some regions can hinder market penetration. The potential for complications during biopsies, such as bleeding, infection, and nerve damage, though rare, also presents a challenge that manufacturers are actively addressing through product design improvements and enhanced safety features. However, significant opportunities exist within this landscape. The development of advanced biopsy guidance systems, including artificial intelligence powered solutions, promises to further enhance diagnostic accuracy and procedural efficiency. Expanding applications of core needle biopsies beyond oncology, into areas like infectious diseases and organ transplantation diagnostics, represent untapped growth avenues. Furthermore, the increasing adoption of value based healthcare models globally is encouraging the use of cost effective and accurate diagnostic tools like core needle biopsy devices, thereby creating new market opportunities.
North America remains the dominant region in the global core needle biopsy devices market, driven by its well developed healthcare infrastructure, high prevalence of cancer, favorable reimbursement policies, and a strong presence of key market players. The region's early adoption of advanced medical technologies and significant investment in research and development activities also contribute to its leading position. Asia Pacific is emerging as the fastest growing region, propelled by improving healthcare access, increasing healthcare expenditure, a large patient pool, and growing awareness regarding early disease diagnosis. Economic development in countries like China and India is leading to a modernization of healthcare facilities and a greater demand for sophisticated medical devices. Key players such as Hanafy Medical, Cook Medical, Siemens Healthineers, Boston Scientific, Terumo, EUSC, Stryker, Toshiba Medical Systems, Medtronic, and Merit Medical Systems are strategically focusing on product innovation, geographic expansion, and collaborations to strengthen their market presence. Their strategies often involve developing new needle designs, integrating advanced imaging capabilities, and expanding distribution networks to cater to the evolving needs of the global healthcare sector.
Quick Stats
Market Size (2025):
USD 1.15 BillionProjected Market Size (2035):
USD 2.12 BillionLeading Segment:
Disposable (72.8% Share)Dominant Region (2025):
North America (38.2% Share)CAGR (2026-2035):
6.7%
What is Core Needle Biopsy Devices?
Core Needle Biopsy Devices are specialized medical instruments used to obtain tissue samples from suspected abnormalities within the body. These devices utilize a hollow needle to extract a small cylindrical core of tissue for microscopic examination. The core concept involves minimizing invasiveness compared to surgical biopsies while providing sufficient tissue for accurate diagnosis of conditions like cancer. Their significance lies in enabling early and precise pathological diagnosis, guiding treatment decisions, and often negating the need for more extensive surgical procedures. Applications span various organs, including breast, lung, liver, and lymph nodes, facilitating the detection of malignant and benign diseases.
What are the Trends in Global Core Needle Biopsy Devices Market
AI Powered Image Guidance for Biopsy Precision
Robotics Revolutionizing Biopsy Accessibility
Enhanced Tissue Characterization with Advanced Probes
Minimally Invasive Techniques Driving Patient Comfort
Point of Care Biopsy Accelerating Diagnostics
AI Powered Image Guidance for Biopsy Precision
AI powered image guidance is revolutionizing biopsy precision within global core needle biopsy devices. This trend leverages sophisticated algorithms to enhance real time visualization during procedures. Instead of traditional static images, AI interprets and highlights suspicious areas with greater accuracy, guiding clinicians to optimal biopsy sites. It analyzes anatomical structures and potential lesions, providing a dynamic roadmap for needle placement. This significantly reduces the likelihood of missing targets or obtaining inadequate samples, improving diagnostic yield and patient outcomes. The technology minimizes the need for repeat biopsies, thereby decreasing patient discomfort and healthcare costs. It empowers physicians with augmented intelligence, transforming how biopsies are performed globally.
Robotics Revolutionizing Biopsy Accessibility
Robotics are significantly enhancing biopsy accessibility within the global core needle biopsy devices market. Traditional biopsy procedures often require specialized medical facilities and highly trained personnel, limiting availability in remote or underserved areas. Robotic systems are overcoming these barriers by enabling more precise and consistent needle placement, even with remote operation capabilities. This technology minimizes human variability and can be deployed in a wider range of clinical settings, including smaller hospitals and outpatient clinics. The increased accuracy and potentially reduced invasiveness also contribute to better patient outcomes. By simplifying the procedural aspects and expanding the reach of trained professionals through teleoperation, robotics are democratizing access to crucial diagnostic tools like core needle biopsies globally. This trend promises to improve early disease detection and treatment for a broader patient population.
What are the Key Drivers Shaping the Global Core Needle Biopsy Devices Market
Rising Incidence and Early Detection of Cancer
Advancements in Imaging Technologies and Minimally Invasive Procedures
Growing Demand for Accurate and Efficient Diagnostic Tools
Increasing Awareness and Adoption of Biopsy Procedures
Favorable Reimbursement Policies and Healthcare Infrastructure Development
Rising Incidence and Early Detection of Cancer
The increasing occurrence of various cancer types globally directly fuels the demand for core needle biopsy devices. As more individuals receive a cancer diagnosis, the necessity for accurate tissue sampling to confirm malignancy and determine its characteristics rises significantly. Concurrently, advancements in screening programs and diagnostic technologies enable earlier detection of suspicious lesions. This proactive approach means more patients undergo biopsies at an earlier stage of potential cancer development, before extensive surgical intervention is necessary. The improved ability to identify subtle changes and abnormalities translates into a greater volume of core needle biopsies performed, thereby driving the adoption and sales of these essential diagnostic tools within healthcare settings worldwide.
Advancements in Imaging Technologies and Minimally Invasive Procedures
Innovations in imaging technologies such as ultrasound, MRI, and CT scans are revolutionizing core needle biopsies. These advancements provide clearer, higher resolution images, allowing physicians to precisely visualize suspicious lesions and guide the biopsy needle with greater accuracy. Real time imaging capabilities minimize the need for repeat procedures and reduce patient discomfort. Simultaneously, the evolution of minimally invasive procedures, driven by these improved imaging modalities, facilitates smaller incisions, less tissue damage, and quicker recovery times. This synergistic development of superior imaging and less invasive techniques enhances diagnostic precision, reduces complications, and improves overall patient outcomes. The increased adoption of these advanced, patient friendly approaches is a significant driver of growth in the global core needle biopsy devices market.
Growing Demand for Accurate and Efficient Diagnostic Tools
The escalating global prevalence of chronic diseases, particularly cancers, is fueling a critical need for precise and timely diagnoses. Clinicians increasingly rely on core needle biopsy devices to obtain high-quality tissue samples essential for definitive disease staging and personalized treatment planning. Traditional diagnostic methods often present limitations in accuracy and efficiency, prompting a significant shift towards advanced biopsy techniques. Patients and healthcare providers alike are demanding instruments that offer greater diagnostic yield, reduced invasiveness, and faster turnaround times. This drive for improved diagnostic confidence across various medical specialties directly propels the adoption and innovation within the global core needle biopsy devices market, making accurate and efficient tools indispensable for modern healthcare.
Global Core Needle Biopsy Devices Market Restraints
Stringent Regulatory Approval Processes for New Devices
Stringent regulatory approval processes for new core needle biopsy devices present a significant restraint. Manufacturers must navigate a complex and lengthy path to bring innovations to market. This involves extensive preclinical testing, demonstrating safety and efficacy through rigorous clinical trials, and submitting detailed documentation to regulatory bodies like the FDA or CE. The high costs associated with these trials, coupled with the substantial time commitment often several years significantly delay product launches. Furthermore, each region may have unique requirements, necessitating tailored approval strategies. This exhaustive scrutiny slows down the introduction of advanced technologies, prolonging the development cycle and increasing financial burdens on companies. Consequently, patient access to newer, potentially more effective devices is delayed, hindering market growth and innovation.
High Cost of Devices and Limited Reimbursement Policies
The high cost of core needle biopsy devices presents a significant impediment to market expansion. Advanced imaging technologies integrated into these devices, coupled with specialized materials and manufacturing processes, elevate their production expenses. Consequently, healthcare providers face substantial acquisition costs, impacting their budget allocations. Furthermore, limited reimbursement policies by government and private insurance payers exacerbate this challenge. In many regions, the existing reimbursement frameworks do not adequately cover the full cost of these sophisticated devices and associated procedures. This discrepancy forces healthcare facilities to absorb a larger portion of the expense or pass it on to patients, making the procedures less accessible. This financial burden restricts widespread adoption, particularly in emerging economies and smaller healthcare settings, thereby hindering the overall growth and penetration of the global core needle biopsy devices market.
Global Core Needle Biopsy Devices Market Opportunities
AI-Enhanced Precision and Automation in Next-Gen Core Needle Biopsy Devices
Integrating Artificial Intelligence into next generation core needle biopsy devices offers a pivotal opportunity to dramatically enhance diagnostic precision and procedural automation. AI algorithms can meticulously analyze medical imaging, providing real time guidance for exact needle placement and optimizing biopsy targeting. This capability significantly improves diagnostic yield by ensuring accurate tissue sample collection from suspicious lesions, thereby reducing the need for repeat procedures and accelerating time to diagnosis.
Furthermore, AI driven automation streamlines various aspects of the biopsy process, from pre procedural planning to automated tissue acquisition. This leads to greater procedural consistency, minimizes operator variability, and boosts overall efficiency in clinical workflows. Such advancements promise reduced patient discomfort, lower complication rates, and enhanced confidence for clinicians. The global market is poised to embrace these innovations, seeking safer, more precise, and efficient diagnostic tools. AI enhanced devices represent a transformative step towards superior patient outcomes and operational excellence in healthcare.
Developing Ultra-Minimally Invasive Devices for Outpatient Core Needle Biopsy
Developing ultra-minimally invasive devices for outpatient core needle biopsy presents a significant opportunity within the global market. Current biopsy techniques can be more invasive, often necessitating hospital environments or extended recovery. The innovation lies in creating smaller, more precise instruments that reduce patient discomfort, minimize tissue damage, and accelerate healing, thereby enabling safe and effective procedures in an outpatient setting. This shift dramatically improves patient convenience and accessibility while simultaneously lowering healthcare system costs. Enhanced patient experience and reduced procedural burden are crucial drivers. This opportunity is particularly compelling in rapidly expanding healthcare markets like Asia Pacific, where demand for efficient, less intrusive diagnostic solutions is soaring due to increasing patient volumes and evolving infrastructure. Devices that streamline diagnostics, require minimal facility support, and prioritize patient comfort will gain substantial traction, capturing a significant segment of the growing market. Manufacturers who focus on these patient centric, cost effective solutions stand to thrive.
Global Core Needle Biopsy Devices Market Segmentation Analysis
Key Market Segments
By Usage Type
- •Disposable
- •Reusable
By Needle Type
- •Automated Needle
- •Manual Needle
- •Vacuum-Assisted Needle
By Application
- •Oncology
- •Cardiology
- •Musculoskeletal Disorders
- •Pulmonary Disorders
By End User
- •Hospitals
- •Diagnostic Laboratories
- •Ambulatory Surgical Centers
Segment Share By Usage Type
Share, By Usage Type, 2025 (%)
- Disposable
- Reusable
www.makdatainsights.com
Why is Disposable Usage Type dominating the Global Core Needle Biopsy Devices Market?
The substantial share of disposable core needle biopsy devices is primarily attributed to stringent infection control regulations and enhanced patient safety. Healthcare facilities increasingly opt for single-use instruments to mitigate risks of cross-contamination and hospital acquired infections. Furthermore, disposables offer convenience, eliminate the need for costly sterilization processes, and ensure consistent performance, making them a preferred choice across various end-user settings.
Which Needle Type segment holds significant importance within the market landscape?
Automated needles represent a crucial segment due to their enhanced precision, speed, and ease of use during biopsy procedures. These devices often feature spring-loaded mechanisms that facilitate rapid tissue acquisition with minimal operator effort, leading to improved diagnostic accuracy and reduced patient discomfort. Vacuum-assisted needles are also significant, particularly for obtaining larger or multiple samples, especially in breast biopsies, further diversifying the market based on procedural requirements.
How does the Application segment influence the overall market dynamics?
Oncology applications account for a predominant share of the core needle biopsy devices market, driven by the escalating global incidence of cancer and the critical need for early and accurate diagnosis. Biopsies are indispensable for definitive cancer diagnosis, staging, and treatment planning across various cancer types. Other applications like cardiology, musculoskeletal, and pulmonary disorders also contribute, but oncology remains the primary demand driver for these diagnostic tools.
What Regulatory and Policy Factors Shape the Global Core Needle Biopsy Devices Market
The global core needle biopsy devices market operates within a complex and stringent regulatory landscape, emphasizing patient safety and device efficacy. Key regulatory bodies include the US Food and Drug Administration, Europe’s Medical Device Regulation, Japan’s Pharmaceuticals and Medical Devices Agency, and China’s National Medical Products Administration. Devices are typically classified as medium to high risk, demanding robust premarket approval pathways. These pathways necessitate extensive clinical evidence, biocompatibility testing, quality management system certifications like ISO 13485, and comprehensive technical documentation. Recent policy shifts, particularly the European Union’s MDR, have significantly heightened post market surveillance, vigilance reporting, and traceability requirements across the product lifecycle. Harmonization efforts by organizations like the International Medical Device Regulators Forum aim to streamline global compliance, though regional variations persist. Manufacturers must navigate diverse national regulations concerning labelling, unique device identification, and data privacy to ensure widespread market access and continued compliance.
What New Technologies are Shaping Global Core Needle Biopsy Devices Market?
Innovations in global core needle biopsy devices are significantly advancing diagnostic capabilities and patient care. Emerging technologies prioritize enhanced precision, reduced invasiveness, and superior sample quality. Advanced imaging integration, particularly real time fusion biopsy combining modalities like MRI and ultrasound, offers unparalleled lesion targeting for complex cases such as prostate and breast cancer. Next generation needle designs feature improved sharpness, specialized tips, and smaller gauges, minimizing patient discomfort and recovery times while optimizing tissue acquisition.
The advent of artificial intelligence is revolutionizing guidance systems, promising more accurate lesion identification and real time trajectory adjustments, thereby reducing operator dependence and variability. Robotic assisted biopsy systems are also gaining traction, providing micron level accuracy and stability for accessing challenging anatomical sites. Furthermore, developments in automated firing mechanisms and vacuum assisted biopsy devices are yielding larger, less fragmented tissue samples, crucial for comprehensive pathological analysis and molecular profiling. These advancements collectively drive improved diagnostic confidence and personalized treatment strategies.
Global Core Needle Biopsy Devices Market Regional Analysis
Global Core Needle Biopsy Devices Market
Trends, by Region
North America Market
Revenue Share, 2025
www.makdatainsights.com
Dominant Region
North America · 38.2% share
North America stands as the dominant region in the Global Core Needle Biopsy Devices Market, commanding a substantial 38.2% market share. This leadership is primarily driven by advanced healthcare infrastructure, high awareness regarding early cancer detection, and significant investment in medical technology. A large patient pool requiring biopsy procedures, coupled with favorable reimbursement policies, further fuels market growth. The presence of key market players and a robust research and development ecosystem contribute to the region's strong position. Moreover, the adoption of minimally invasive procedures and technological advancements in biopsy devices solidify North America's continued prominence in the market, reflecting a mature and highly innovative healthcare landscape.
Fastest Growing Region
Asia Pacific · 9.2% CAGR
Asia Pacific stands as the fastest growing region in the Global Core Needle Biopsy Devices Market, projecting a robust CAGR of 9.2% during the 2026-2035 forecast period. This significant expansion is driven by several key factors. Increasing healthcare expenditure across emerging economies is improving access to advanced diagnostic tools. A rising prevalence of cancer, particularly breast and lung cancer, necessitates more frequent and accurate biopsy procedures. Furthermore, growing awareness about early disease detection and the benefits of minimally invasive biopsy techniques are fueling market demand. Technological advancements in imaging and biopsy device design, coupled with improving healthcare infrastructure, especially in countries like China and India, further solidify Asia Pacifics leading growth trajectory in this vital medical device sector.
Top Countries Overview
The U.S. leads the global core needle biopsy devices market, driven by rising cancer incidence and demand for early diagnosis. Technological advancements, particularly in image-guided biopsy and robotic systems, are bolstering market expansion. Favorable reimbursement policies and increasing awareness campaigns further contribute to the U.S.'s dominant position, fostering innovation and significant market growth within this crucial medical device sector.
China is a pivotal force in the global core needle biopsy devices market, experiencing robust growth driven by increasing cancer rates and improving healthcare infrastructure. Local manufacturers are gaining market share, emphasizing innovation in imaging guidance and automation. The market benefits from government support for early cancer detection and domestic production. While international players maintain strong presence, China's market dynamics increasingly favor domestic competition and technological advancements, significantly impacting global supply and demand.
India's Global Core Needle Biopsy Devices Market is growing, driven by rising cancer incidence and demand for minimally invasive diagnostics. However, high device costs and limited access in rural areas pose challenges. Key players are investing in local manufacturing and expanding distribution networks to capitalize on this expanding market.
Impact of Geopolitical and Macroeconomic Factors
Geopolitical factors influence the core needle biopsy devices market through healthcare spending priorities and supply chain vulnerabilities. Rising geopolitical tensions could divert government resources from healthcare infrastructure development, particularly in developing nations, impacting access to advanced diagnostic tools. Conversely, increased focus on healthcare resilience in the face of global crises might accelerate adoption of these devices to improve diagnostic capabilities. Trade policies and intellectual property enforcement also play a role; protectionist measures could disrupt the flow of components and finished products, leading to price increases or availability issues.
Macroeconomic conditions directly affect market growth. Economic downturns reduce discretionary healthcare spending, potentially delaying or restricting access to advanced biopsy procedures. Inflationary pressures increase manufacturing costs for devices, potentially translating to higher prices for end-users and impacting budget allocations for hospitals and clinics. Exchange rate fluctuations influence the profitability of international sales and the cost of imported components. Investment in medical technology research and development, often driven by overall economic health, dictates the pace of innovation and introduction of new, more effective devices.
Recent Developments
- March 2025
Cook Medical announced the launch of its next-generation multi-fire core needle biopsy device, featuring enhanced needle visibility and improved tissue sample collection capabilities. This advancement aims to provide clinicians with greater precision and diagnostic accuracy in various biopsy procedures.
- September 2024
Siemens Healthineers and EUSC formed a strategic partnership to integrate advanced imaging guidance systems with EUSC's innovative core needle biopsy devices. This collaboration seeks to optimize procedural workflows and improve outcomes for minimally invasive biopsies, particularly in challenging anatomical locations.
- July 2025
Medtronic completed the acquisition of a specialized start-up focused on AI-powered tissue analysis for core needle biopsy samples. This strategic move aims to enhance Medtronic's diagnostic offerings by providing more rapid and accurate pathology results, thereby streamlining the diagnostic pathway for patients.
- November 2024
Boston Scientific introduced a new line of disposable core needle biopsy devices designed for single-use applications, emphasizing sterility and reducing the risk of cross-contamination. The product line incorporates ergonomic improvements for better clinician handling and patient comfort during procedures.
- February 2025
Merit Medical Systems initiated a global clinical trial for its novel steerable core needle biopsy system, engineered to navigate complex lesions with greater control and reduce patient discomfort. The trial aims to demonstrate superior maneuverability and sample retrieval rates compared to conventional devices.
Key Players Analysis
The global core needle biopsy devices market is shaped by major players like Cook Medical and Medtronic, known for their comprehensive portfolios and extensive market reach. Siemens Healthineers and Toshiba Medical Systems leverage their imaging expertise to integrate biopsy devices with advanced visualization technologies, enhancing precision. Boston Scientific and Stryker focus on innovative device design, often incorporating robotic assistance or navigation systems for improved accuracy and patient safety. Terumo and Merit Medical Systems emphasize device versatility and ease of use, while Hanafy Medical and EUSC represent specialized innovators bringing novel biopsy approaches to market. Strategic initiatives include R&D for minimally invasive and image guided biopsy devices, geographic expansion, and partnerships, all driving market growth through improved diagnostic capabilities and patient outcomes.
List of Key Companies:
- Hanafy Medical
- Cook Medical
- Siemens Healthineers
- Boston Scientific
- Terumo
- EUSC
- Stryker
- Toshiba Medical Systems
- Medtronic
- Merit Medical Systems
- BD
- C.R. Bard
- Canon Medical Systems
- Hologic
- B. Braun Melsungen
- Cardinal Health
Report Scope and Segmentation
| Report Component | Description |
|---|---|
| Market Size (2025) | USD 1.15 Billion |
| Forecast Value (2035) | USD 2.12 Billion |
| CAGR (2026-2035) | 6.7% |
| Base Year | 2025 |
| Historical Period | 2020-2025 |
| Forecast Period | 2026-2035 |
| Segments Covered |
|
| Regional Analysis |
|
Table of Contents:
List of Figures
List of Tables
Table 1: Global Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Usage Type, 2020-2035
Table 2: Global Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Needle Type, 2020-2035
Table 3: Global Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 4: Global Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by End User, 2020-2035
Table 5: Global Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Region, 2020-2035
Table 6: North America Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Usage Type, 2020-2035
Table 7: North America Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Needle Type, 2020-2035
Table 8: North America Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 9: North America Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by End User, 2020-2035
Table 10: North America Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Country, 2020-2035
Table 11: Europe Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Usage Type, 2020-2035
Table 12: Europe Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Needle Type, 2020-2035
Table 13: Europe Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 14: Europe Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by End User, 2020-2035
Table 15: Europe Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 16: Asia Pacific Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Usage Type, 2020-2035
Table 17: Asia Pacific Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Needle Type, 2020-2035
Table 18: Asia Pacific Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 19: Asia Pacific Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by End User, 2020-2035
Table 20: Asia Pacific Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 21: Latin America Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Usage Type, 2020-2035
Table 22: Latin America Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Needle Type, 2020-2035
Table 23: Latin America Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 24: Latin America Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by End User, 2020-2035
Table 25: Latin America Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 26: Middle East & Africa Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Usage Type, 2020-2035
Table 27: Middle East & Africa Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Needle Type, 2020-2035
Table 28: Middle East & Africa Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 29: Middle East & Africa Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by End User, 2020-2035
Table 30: Middle East & Africa Core Needle Biopsy Devices Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035